Long-Term Capital Gains Treatment for Patent Transfers
IRC §1235
Treats the transfer of all substantial rights to a patent as a sale of a capital asset held for more than 1 year, regardless of the actual holding period.
Eligibility
Applies to 'holders' (the creator or an individual who funded the creator before the invention was reduced to practice) who transfer all substantial rights to a patent to an unrelated party.
Frequently Asked Questions
Who is eligible for the Long-Term Capital Gains Treatment for Patent Transfers?
Applies to 'holders' (the creator or an individual who funded the creator before the invention was reduced to practice) who transfer all substantial rights to a patent to an unrelated party.
How does the Long-Term Capital Gains Treatment for Patent Transfers work?
Treats the transfer of all substantial rights to a patent as a sale of a capital asset held for more than 1 year, regardless of the actual holding period.
What law authorizes the Long-Term Capital Gains Treatment for Patent Transfers?
The Long-Term Capital Gains Treatment for Patent Transfers is authorized under IRC §1235 of the Internal Revenue Code (Title 26, United States Code).
Statutory Text — IRC §1235
Source: Internal Revenue Code, Title 26, United States Code
Showing first 3,000 characters of full section text.
Legal Sources
US Code (Official) — 26 USC §1235 → Cornell Law Institute — 26 USC §1235 → Search IRS.gov for IRC §1235 → Treasury Regulations (26 CFR) →Discovered by: discovery_engine_v1
Calculator handler: generic pattern